SCHEMBL17532775

SCHEMBL17532775

Cc1cc2ccc3c(C)nccc3c2c(C)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2A6 P11509 1/20 0.40
▸ KDM4E B2RXH2 4/20 0.36
▸ LMNA P02545 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ MAOA P21397 5/20 0.35
▸ PDE3B Q13370 3/20 0.35
▸ PDE3A Q14432 3/20 0.35
▸ CCNB2 O95067 2/20 0.34
▸ CDK1 P06493 2/20 0.34
▸ CCNB1 P14635 2/20 0.34
▸ CCNA2 P20248 2/20 0.34
▸ CDK2 P24941 2/20 0.34
▸ CCNA1 P78396 2/20 0.34
▸ CDK5 Q00535 2/20 0.34
▸ CDK5R1 Q15078 2/20 0.34
▸ CCNB3 Q8WWL7 2/20 0.34
▸ CHRM4 P08173 2/20 0.34
▸ DYRK1A Q13627 4/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ CYP1A2 P05177 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17532780 0.81 KDM4E (0.40) KDM4ELMNAHTTDYRK1AALDH1A1
SCHEMBL17532774 0.81 CYP2A6 (0.50) CYP2A6KDM4ELMNAMAOAPDE3B
SCHEMBL17532788 0.79 CYP2A6 (0.39) CYP2A6KDM4ELMNAHTTMAOA
SCHEMBL17532778 0.79 CYP2A6 (0.40) CYP2A6KDM4ELMNAHTTMAOA
SCHEMBL17532793 0.76 KDM4E (0.42) CYP2A6KDM4ELMNAHTTALDH1A1
SCHEMBL17532781 0.75 CYP2A6 (0.41) CYP2A6KDM4ELMNAMAOAPDE3B
SCHEMBL17532790 0.74 CYP1A2 (0.44) CYP2A6KDM4ELMNAHTTCYP1A2
SCHEMBL12266516 0.73 CYP2A6 (0.56) CYP2A6KDM4EMAOAPDE3BPDE3A
SCHEMBL17532777 0.73 CYP1A2 (0.47) CYP2A6KDM4ELMNAHTTDYRK1A
SCHEMBL17532764 0.73 CYP1A2 (0.46) KDM4ELMNAHTTALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9780310-B2 Heterocyclic compound for organic electroluminescent device and its application TOSOH CORPORATION (JP) 2017-10-03 — — US disclosed
US-20160056388-A1 HETEROCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ITS APPLICATION TOSOH CORPORATION (JP) 2016-02-25 — — US disclosed
US-20160056388-A1 HETEROCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ITS APPLICATION TOSOH CORPORATION (JP) 2016-02-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160056388-A1 HETEROCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ITS APPLICATION AOC2, AZI2, KCNH2 CYP2A6 3145/4885KDM4E 995/4885LMNA 2238/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback